US Patent Issued to UNIVERSITY OF KANSAS on Oct. 6 for "Therapeutic uses of inhibitors of the RNA-binding protein HuR" (Kansas Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,938, issued on Oct. 6, was assigned to UNIVERSITY OF KANSAS (Lawrence, Kan.).

"Therapeutic uses of inhibitors of the RNA-binding protein HuR" was invented by Liang Xu (Lawrence, Kan.), Xiaoqing Wu (Lawrence, Kan.), Lan Lan (Lawrence, Kan.) and Jeff Aube (Chapel Hill, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology is directed to methods of treatment utilizing inhibitors of HuR interaction with RNA, where the inhibitors are of Formula I where R1 is; and X1 is OH, NH-OH, or 0-(C1-C8 unsubstituted alkyl)."

The patent was filed on March 22, 2021, under Application No. 17/914,287.

*For further information, including images, ch...